儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版)

2019-09-05 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

儿童非横纹肌肉瘤类软组织肉瘤(non-habdomyosarcoma soft tissue sarcomas,NRSTs )是除横纹肌肉瘤外所有软组织肉瘤的统称,肿瘤可发生于头颈部、四肢、胸壁、内脏等全身任何解剖部位,组织起源于肌肉、肌腱、脂肪、淋巴管、血管、滑膜以及纤维组织等,有很强异质性。其病理类型多样,生物学特性差异大。主要包括滑膜肉瘤( synovial sarcoma )、血管周细胞瘤

中文标题:

儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版)

发布日期:

2019-09-05

简要介绍:

儿童非横纹肌肉瘤类软组织肉瘤(non-habdomyosarcoma soft tissue sarcomas,NRSTs )是除横纹肌肉瘤外所有软组织肉瘤的统称,肿瘤可发生于头颈部、四肢、胸壁、内脏等全身任何解剖部位,组织起源于肌肉、肌腱、脂肪、淋巴管、血管、滑膜以及纤维组织等,有很强异质性。其病理类型多样,生物学特性差异大。主要包括滑膜肉瘤( synovial sarcoma )、血管周细胞瘤( hemangiosarcoma )、恶性外周神经鞘瘤( malignant peripheral nerve sheath tumor)、上皮样肉瘤(epithelioid sarcoma)、婴儿型纤维肉瘤、纤维肉瘤(fibrosarcoma)、炎性肌纤维母细胞瘤( inflammatory myofibroblastic tumours,IMTs)、隆突性皮肤纤维肉瘤(DFSP)、腺泡状软组织肉瘤(alveolar soft -part sarcoma,ASTS),韧带样纤维瘤病(desmoid fibromatosis)、恶性纤维组织细胞瘤以及未归类肉瘤等。

 

拓展指南:肉瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版))] GetToolGuiderByIdResponse(projectId=1, id=e6f051c001e9355c, title=儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=儿童非横纹肌肉瘤类软组织肉瘤(non-habdomyosarcoma soft tissue sarcomas,NRSTs )是除横纹肌肉瘤外所有软组织肉瘤的统称,肿瘤可发生于头颈部、四肢、胸壁、内脏等全身任何解剖部位,组织起源于肌肉、肌腱、脂肪、淋巴管、血管、滑膜以及纤维组织等,有很强异质性。其病理类型多样,生物学特性差异大。主要包括滑膜肉瘤( synovial sarcoma )、血管周细胞瘤, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>儿童非横纹肌肉瘤类软组织肉瘤(non-habdomyosarcoma soft tissue sarcomas,NRSTs )是除横纹肌肉瘤外所有软组织肉瘤的统称,肿瘤可发生于头颈部、四肢、胸壁、内脏等全身任何解剖部位,组织起源于肌肉、肌腱、脂肪、淋巴管、血管、滑膜以及纤维组织等,有很强异质性。其病理类型多样,生物学特性差异大。主要包括滑膜肉瘤( synovial sarcoma )、血管周细胞瘤( hemangiosarcoma )、恶性外周神经鞘瘤( malignant peripheral nerve sheath tumor)、上皮样肉瘤(epithelioid sarcoma)、婴儿型纤维肉瘤、纤维肉瘤(fibrosarcoma)、炎性肌纤维母细胞瘤( inflammatory myofibroblastic tumours,IMTs)、隆突性皮肤纤维肉瘤(DFSP)、腺泡状软组织肉瘤(alveolar soft -part sarcoma,ASTS),韧带样纤维瘤病(desmoid fibromatosis)、恶性纤维组织细胞瘤以及未归类肉瘤等。</P> <P> </P>拓展指南:<strong>与<font color=red>肉瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=f3ec31c001e82811" title="NCCN临床实践指南:软组织肉瘤(2019.V3)" target=_blank>NCCN临床实践指南:软组织肉瘤(2019.V3)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=094401c001e639f1" title="原发性腹膜后软组织肉瘤诊治中国专家共识(2019版)" target=_blank>原发性腹膜后软组织肉瘤诊治中国专家共识(2019版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b09011c001ea3420" title="2018 隆突性皮肤纤维肉瘤指南(更新版)" target=_blank>2018 隆突性皮肤纤维肉瘤指南(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5c4981c001e39186" title="2019 EDF/EADO/EORTC欧洲跨学科指南:卡波西肉瘤的诊断和治疗" target=_blank>2019 EDF/EADO/EORTC欧洲跨学科指南:卡波西肉瘤的诊断和治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5e38f1c001e18a3c" title="四肢骨肉瘤保肢治疗指南" target=_blank>四肢骨肉瘤保肢治疗指南</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%89%E7%98%A4" target=_blank>有关肉瘤更多指南</a></ul>, tagList=[TagDto(tagId=94722, tagName=儿童非横纹肌肉瘤类软组织肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12490, appHits=176, showAppHits=0, pcHits=10762, showPcHits=2606, likes=62, shares=4, comments=5, approvalStatus=1, publishedTime=Sun Sep 22 22:11:07 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:11:07 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:06:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版))])
儿童及青少年非横纹肌肉瘤类软组织肉瘤诊疗规范(2019版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2142815, encodeId=64f6214281591, content=太棒 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55805094640, createdName=145de854m17暂无昵称, createdTime=Wed Jun 14 22:52:07 CST 2023, time=2023-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1012043, encodeId=05ab1012043de, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145d5458858, createdName=ms5000000727844683, createdTime=Fri Aug 27 13:28:16 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965866, encodeId=e1ad9658662f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b68c2329024, createdName=1226741fm39(暂无昵称), createdTime=Sat May 15 15:44:16 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895380, encodeId=afe389538008, content=指导意义很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/2a8273a0f8d34d10baae98ab03ee8bdc/083e1bc82d3a438891b1052e1192a529.jpg, createdBy=fd361960002, createdName=1e13341am66(暂无匿称), createdTime=Thu Oct 29 11:07:32 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2023-06-14 145de854m17暂无昵称 来自福建省

    太棒 很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2142815, encodeId=64f6214281591, content=太棒 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55805094640, createdName=145de854m17暂无昵称, createdTime=Wed Jun 14 22:52:07 CST 2023, time=2023-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1012043, encodeId=05ab1012043de, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145d5458858, createdName=ms5000000727844683, createdTime=Fri Aug 27 13:28:16 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965866, encodeId=e1ad9658662f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b68c2329024, createdName=1226741fm39(暂无昵称), createdTime=Sat May 15 15:44:16 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895380, encodeId=afe389538008, content=指导意义很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/2a8273a0f8d34d10baae98ab03ee8bdc/083e1bc82d3a438891b1052e1192a529.jpg, createdBy=fd361960002, createdName=1e13341am66(暂无匿称), createdTime=Thu Oct 29 11:07:32 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-08-27 ms5000000727844683

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2142815, encodeId=64f6214281591, content=太棒 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55805094640, createdName=145de854m17暂无昵称, createdTime=Wed Jun 14 22:52:07 CST 2023, time=2023-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1012043, encodeId=05ab1012043de, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145d5458858, createdName=ms5000000727844683, createdTime=Fri Aug 27 13:28:16 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965866, encodeId=e1ad9658662f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b68c2329024, createdName=1226741fm39(暂无昵称), createdTime=Sat May 15 15:44:16 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895380, encodeId=afe389538008, content=指导意义很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/2a8273a0f8d34d10baae98ab03ee8bdc/083e1bc82d3a438891b1052e1192a529.jpg, createdBy=fd361960002, createdName=1e13341am66(暂无匿称), createdTime=Thu Oct 29 11:07:32 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-05-15 1226741fm39(暂无昵称)

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2142815, encodeId=64f6214281591, content=太棒 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55805094640, createdName=145de854m17暂无昵称, createdTime=Wed Jun 14 22:52:07 CST 2023, time=2023-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1012043, encodeId=05ab1012043de, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145d5458858, createdName=ms5000000727844683, createdTime=Fri Aug 27 13:28:16 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965866, encodeId=e1ad9658662f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b68c2329024, createdName=1226741fm39(暂无昵称), createdTime=Sat May 15 15:44:16 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895380, encodeId=afe389538008, content=指导意义很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/2a8273a0f8d34d10baae98ab03ee8bdc/083e1bc82d3a438891b1052e1192a529.jpg, createdBy=fd361960002, createdName=1e13341am66(暂无匿称), createdTime=Thu Oct 29 11:07:32 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 1e13341am66(暂无匿称)

    指导意义很强

    0